12 Health Care Stocks Moving In Friday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's pre-market session, several healthcare stocks showed significant movement. Gainers included China SXT Pharmaceuticals, MediciNova, Sarepta Therapeutics, Ikena Oncology, Sientra, and Artivion, with increases ranging from 10.86% to 25.2%. Losers were Inventiva, T2 Biosystems, Healthcare Triangle, Hepion Pharmaceuticals, Cardio Diagnostics Hldgs, and AMN Healthcare Services, with decreases ranging from 7.26% to 8.6%. Notably, earnings reports influenced several of these movements.
February 16, 2024 | 1:06 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
AMN Healthcare Services shares fell 7.26% to $72.0 following their Q4 earnings report.
The decrease is likely due to the market's negative response to the Q4 earnings report, suggesting concerns over the company's financial health or future prospects.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 95
NEGATIVE IMPACT
Cardio Diagnostics Hldgs stock decreased by 7.31% to $1.65, with a market cap of $34.8 million.
The decline could reflect broader market trends or specific concerns among investors regarding the company's outlook.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Healthcare Triangle shares fell 7.66% to $2.51, with a market cap of $10.8 million.
The drop could be due to negative investor sentiment or reactions to recent company or industry developments.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Hepion Pharmaceuticals shares fell 7.41% to $2.5, with a market cap of $10.8 million.
The decrease may be attributed to investor concerns or negative reactions to company-specific news or broader market conditions.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Inventiva shares decreased by 8.6% to $3.6, with a market cap of $185.9 million.
The decrease may reflect investor concerns or negative market reactions, possibly due to company-specific news or broader market trends.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85
NEGATIVE IMPACT
T2 Biosystems shares declined by 7.67% to $5.9 following their Q4 earnings release.
The decline likely results from the market's negative reaction to the Q4 earnings report, indicating concerns over financial performance or outlook.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 95
POSITIVE IMPACT
Artivion stock increased by 10.86% to $20.0 following their Q4 earnings report.
The stock's increase is likely a reaction to a favorable Q4 earnings report, indicating strong financial health or future prospects.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 95
POSITIVE IMPACT
Ikena Oncology shares rose 12.32% to $1.64, with a market cap of $79.1 million.
The increase suggests investor confidence in Ikena Oncology's potential, possibly due to recent company news or industry trends.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
MediciNova's stock rose by 17.77% to $1.59 following their Q4 earnings release.
The increase is likely a direct response to the positive reception of their Q4 earnings report, indicating strong financial performance or outlook.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 95
POSITIVE IMPACT
Sientra's stock increased by 11.4% to $0.38, with a market cap of $4.5 million.
The rise could be due to speculative trading or positive developments within the company, attracting investor interest.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Sarepta Therapeutics' shares increased by 14.5% to $143.0, with a market cap of $13.3 billion.
The upward movement could be attributed to positive investor sentiment towards the company's market position or recent developments.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
China SXT Pharmaceuticals saw a 25.2% increase to $2.73, with a market cap of $1.5 million.
The significant pre-market increase suggests positive investor sentiment, potentially due to speculative trading or recent company developments.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90